Karen L. Smith

AUPH

Karen L. Smith serves as Director at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$62.7K

Net Position

Net Seller

$62.7K

Companies Traded

AUPH, EBS

Active Period

May 2021 – Nov 2024

2 total trades

Most Recent

Sell AUPH

Nov 8, 2024 · $44.2K

Karen L. Smith's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

0 · $0.00

Sells

1 · $44.2K

Total Shares Bought

Total Shares Sold

5,241

AUPH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 8, 2024↗	Sell	5,241	$8.43	$44.2K	0

Karen L. Smith's Insider Trading at Emergent BioSolutions Inc. (EBS)

Buys

0 · $0.00

Sells

1 · $18.6K

Total Shares Bought

Total Shares Sold

305

EBS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 7, 2021↗	Sell	305	$60.85	$18.6K	0

Related Insiders

Matthew Maxwell Donley

Chief Operating Officer

AUPHSell · Feb 20, 2026

Peter Greenleaf

Chief Executive Officer

AUPHSell · Feb 20, 2026

Joseph M Miller

Chief Financial Officer

AUPHSell · Feb 20, 2026

Stephen P. Robertson

EVP, General Counsel

AUPHSell · Feb 20, 2026

Jessica Perl

SVP, General Counsel, Corp Sec

EBSSell · Feb 9, 2026

William Hartzel

SVP, Bioservices

EBSSell · Feb 6, 2026

Coleen Glessner

EVP, Quality & Ethics, and CPL

EBSSell · Feb 6, 2026

LINDAHL RICHARD S

EVP, Chief Financial Officer

EBSSell · Feb 6, 2026

Explore More Insider Trading Data

AUPH Insider Trading Activity

View all insider trades at Aurinia Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity